Lilly Gets Second Interchangeable Insulin Glargine In US

Further FDA Approval For Rezvoglar Biosimilar Adds Second Interchangeable Option

 
• By David Wallace
  
Eli Lilly Sign On Building
Lilly’s Rezvoglar has been approved as interchangeable by the FDA • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products